Merck science “like wah, wah, wah”
As reported in yesterday's Wall Street Journal ("Merck Loss Jolts Drug Giant, Industry"; 8/22/2005). the jurors in the first Vioxx liability case dismissed the...
Jury as Focus Group
While Merck is pre-occupied planning its appeal of last week's judgment against the company in the first Vioxx liability case, it is hoped that...
Merck Found Negligent!
As reported by the Wall Street Journal: "Merck & Co. was found negligent in the death of a 59-year-old triathlete who used Vioxx, a...
Pharma Marketing Newspeak
Although I am willing to forgive a little bit of pharma marketing BS (see "Is pharmaceutical Marketing BS?"), I am queasy about out-and-out deception,...
Alternative to DTC: cDetailing
Last week I posted what I hoped would be the beginning of a series of ideas about alternatives to DTC (see "Alternatives to DTC,...
Movies and Drugs: Same Blockbuster Mentality
You are probably aware of certain connections between Hollywood and Raritan (the nexus of Pharma's heartland); i.e., between the movie industry and the drug...
Pfizer DTC Pledge: ED is Litmus Test
Pfizer recently announced changes to its direct-to-consumer (DTC) advertising of prescription drugs (see "Pfizer Announces Improvements to Consumer Advertising for Prescription Medicines"). The Pfizer...
Internet Marketing: Risks Ahead
In an Ad Age story ("Marketers Wrestle with Hard-to-Control" Web Content") doubt is cast upon the wisdom of advertising on blogs because such consumer-controlled...
Bloggers Worry Pharma More Than FDA
Billy Tauzin, CEO of PhRMA, the US drug industry trade group, laid into the FDA's proposal for a Drug Watch site (see "FDA Drug...
Alternatives to DTC, Part 1
Recently, the following items have appeared in my radar screen: Last week I was visited by two entrepreneurs who showed...
